The April 2017 issue is available!


Please click here to access the January 2016 Psychiatry Letter as your free sample issuelectronically!
If you like what you see, please subscribe below.


The Psychiatry Letter provides analysis on diagnosis and therapeutics based on our best scientific evidence and our most convincing psychiatric concepts, even if they conflict with the conventional wisdom, including DSM labels or FDA indications. 

Unlike many other clinical advice or newsletter sites, our articles are written by active clinicians who are also researchers, with extensive scientific credibility, with hundreds of scientific articles or books. 



Please subscribe to receive premium content available only to subscribers on the website and in a monthly newsletter. 


Each newsletter issue will include:  A special article, a study of the month, a drug of the month, a clinical case of the month, and curbside consults (responses to questions and cases from you).  Issues will also include, depending on the month, installments in an ongoing psychopharmacology course, a psychopathology article, or a psychotherapy article.


Free 30-day trial
Paypal



Subscribe to online access only
(
US$ 90.00 yearly)
Paypal, credit or debit card accepted.



Subscribe to print and online access - US only
(
US$ 149.00 yearly)
Paypal, credit or debit card accepted.



Institutional Subscription
(
US$ 499.00 yearly)
Paypal, credit or debit card accepted.



Hospital Subscription
(
US$ 299.00 yearly)
Paypal, credit or debit card accepted.



Subscribe to print and online access - Canada only
(
US$ 145.00 yearly)
Paypal, credit or debit card accepted.



Subscribe to online access - Residents/trainees/students discount    (US$ 60.00 yearly)

Read our policy

Forgot your ID or password?

Meet our expert EDITORIAL BOARD, composed of clinicians and researchers from around the world. 

Subscribe to the RSS feed below to follow our "What's new" blog posts